The West African Postgraduate College of Pharmacists (WAPCP), Nigeria Chapter, has officially commenced its 8th Scientific Conference and Annual General Meeting, issuing a resolute call to the Federal Government, state administrations, and public health institutions to prioritize the full implementation of the consultant pharmacist cadre across the federation. This appeal, central to the conference’s agenda, underscores the critical need for specialized pharmaceutical intervention to mitigate medication errors, optimize therapeutic outcomes, and fortify the nation’s evolving healthcare infrastructure. Speaking at a high-level press conference held at the Pharmacists Council of Nigeria (PCN) Auditorium in Yaba, Lagos, Chapter Chairman Dr. Afusat Adesina emphasized that the expansion of clinical roles for pharmacists is no longer a professional luxury but a public health necessity.
The conference, which spans from July 12 to 14, 2026, serves as a pivotal platform for healthcare stakeholders to deliberate on the theme, "Expanding Consultant Pharmacists’ Clinical Roles in Nigeria to Optimize Patient Care and Medication Safety." According to Dr. Adesina, the integration of consultant pharmacists into the multidisciplinary healthcare team is a proven strategy for reducing the incidence of adverse drug reactions, which remain a leading cause of morbidity and mortality in hospital settings. While the Federal Ministry of Health has officially approved the cadre, the pace of adoption at the sub-national level and within specific tertiary institutions remains inconsistent, prompting the College to demand accelerated domestication of the policy.
The State of Implementation and Institutional Barriers
Providing a comprehensive situational report on the progress of the consultant pharmacist cadre, Dr. Adesina revealed a landscape of mixed results. While the Federal Government’s approval marked a landmark achievement for the profession, the transition from policy to practice has faced significant hurdles. Current data indicates that only eight teaching hospitals and nine Federal Medical Centres (FMCs) have fully implemented the cadre. At the state level, the disparity is even more pronounced, with only five states having domesticated the policy.
Specific institutions, including the Lagos University Teaching Hospital (LUTH), the University of Abuja Teaching Hospital, and the Aminu Kano Teaching Hospital, were identified as notable laggards in the implementation process. Similarly, despite being major healthcare hubs, states such as Lagos, Kaduna, and Enugu have yet to fully integrate consultant pharmacists into their civil service structures. Conversely, Dr. Adesina lauded the proactive steps taken by states like Niger, Osun, Adamawa, and Katsina, as well as the two branches of the Nigerian Armed Forces medical facilities that have already embraced the new cadre.
"We are not where we want to be, but we are certainly not where we started," Dr. Adesina remarked. "The Federal Government has provided the framework; it is now incumbent upon state governors and hospital boards to recognize that the consultant pharmacist is a vital partner in the quest for clinical excellence. Every day that the implementation is delayed is a day that patients are denied the highest standard of specialized pharmaceutical care."
Addressing the Public Health Crisis of Medication Mismanagement
A core objective of the WAPCP conference is to address the alarming rise in irrational drug use and the proliferation of unregistered medicine outlets. The College expressed deep concern over the prevalence of self-medication among Nigerians, which often leads to irreversible health complications. Consultant pharmacists, by virtue of their advanced training, are uniquely positioned to provide the oversight necessary to curb these trends.
Dr. Adesina warned that the purchase of medicines from unlicensed vendors and the use of prescription drugs without professional supervision are major drivers of chronic health conditions in Nigeria. "Medication safety is a global priority, yet in Nigeria, lives are frequently lost and resources wasted because medicines are used incorrectly," she stated. "A registered pharmacist is trained to ensure that the right drug reaches the right patient in the right dose. Beyond that, a consultant pharmacist provides the clinical depth to manage complex therapy regimens, preventing errors that lead to kidney damage, liver failure, and mental health crises."
The College also highlighted the "silent pandemic" of antimicrobial resistance (AMR). By expanding the clinical roles of pharmacists, the healthcare system can better implement antimicrobial stewardship programs, ensuring that antibiotics are used judiciously to preserve their efficacy for future generations.
Scientific Innovation and the Role of Artificial Intelligence
The 8th Scientific Conference marks a significant evolution for the WAPCP Nigeria Chapter, transitioning from a standard annual meeting to a robust scientific symposium. Dr. Abubakar Danraka, Chairman of the Conference Planning Committee, disclosed that the event would feature 21 scientific abstracts presented through oral and poster sessions. These presentations focus on evidence-based pharmacy practice, ranging from clinical trials to community-based health interventions.
A major highlight of this year’s gathering is the focus on emerging technologies. Capacity-building workshops have been designed to train pharmacists on the application of Artificial Intelligence (AI) in pharmacy practice and research. AI-driven tools are increasingly being used globally to predict drug-drug interactions, personalize medication dosages based on genetic profiles, and streamline hospital inventory management. Dr. Danraka emphasized that for Nigeria to remain competitive in the global health landscape, its pharmacists must be proficient in leveraging data systems and health technology.
"We are looking at how AI can revolutionize patient monitoring and research," Dr. Danraka explained. "By integrating technology with clinical expertise, we can move from reactive treatment to proactive, personalized pharmaceutical care."
Strengthening Local Manufacturing and Medicine Security
Beyond clinical practice, the conference is tackling the economic and structural challenges facing Nigeria’s pharmaceutical industry. Despite having over 160 pharmaceutical manufacturing companies, Nigeria remains heavily dependent on foreign imports for Active Pharmaceutical Ingredients (APIs) and essential raw materials. This vulnerability was laid bare during global supply chain disruptions, which led to scarcity and skyrocketing prices of essential medicines.
Dr. Danraka observed that nearly 99% of APIs used in local production are currently imported. However, he expressed optimism regarding the Federal Government’s "Presidential Initiative on Unlocking the Healthcare Value Chain." This strategic intervention aims to provide the necessary incentives for local manufacturers to begin synthesizing raw materials domestically.
"If the government sustains these interventions over the next five to ten years, Nigeria can transform into a leading pharmaceutical hub for the African continent," Danraka said. "Medicine security is a component of national security. We cannot rely entirely on external sources for the health of our citizens. Strengthening local manufacturing is the only path to sustainable patient care and affordable medicine."
Overcoming Professional Misconceptions and Resistance
One of the most significant barriers to the full implementation of the consultant pharmacist cadre has been institutional resistance, often rooted in misconceptions about the role of the pharmacist relative to other medical professionals. Dr. Solomon Kelechi Mwafuru, representing the Association of Consultant Pharmacists of Nigeria (ASCOP), addressed these tensions directly during the press conference.
Dr. Mwafuru clarified that consultant pharmacists are not in competition with physicians. Instead, they serve as complementary specialists within a multidisciplinary team. In modern healthcare, the complexity of drug therapies requires a level of specialization that focuses specifically on the chemistry, pharmacology, and clinical application of medicines.
"In developed healthcare systems, the physician diagnoses and prescribes, while the consultant pharmacist ensures the prescription is optimized for the patient’s specific physiological needs, monitoring for side effects and long-term efficacy," Dr. Mwafuru noted. "Nigeria must move past these territorial disputes. When we work together, the patient wins. Consultant pharmacists bring expertise in research, leadership, and clinical education that strengthens the entire hospital ecosystem."
A Vision for the Future of Pharmacy in Nigeria
The conference also received support from the Clinical Pharmacists Association of Nigeria (CPAN), with representative Dr. Oke Timipre reaffirming the association’s commitment to advocacy. The collective voice of WAPCP, ASCOP, and CPAN signals a unified front in the push for professional recognition and healthcare reform.
As the 8th Scientific Conference and Annual General Meeting continues, the unveiling of the rebranded WAPCP Nigeria Chapter newsletter will serve as a permanent record of these advocacy efforts and scientific advancements. The College remains steadfast in its mission to produce highly skilled specialists who can navigate the complexities of 21st-century medicine.
The consensus among the experts is clear: the full implementation of the consultant pharmacist cadre is a vital step toward a safer, more efficient, and more resilient Nigerian healthcare system. By domesticating this policy, the government will not only be fulfilling a professional mandate but will also be making a profound investment in the life expectancy and well-being of every Nigerian citizen. The conference concludes with a call to action for all health stakeholders to embrace a collaborative model of care where the pharmacist’s clinical expertise is fully utilized at the bedside and in the boardroom.
